Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 4, 2009, Pages 213-218

  Jingting, Jiang ^a   Changping, Wu ^a   Ning, Xu ^b   Yibei, Zhu ^c   Jun, Wu ^a   Mei, Ji ^a   Bin, Xu ^a   Peter, Nilsson Ehle ^b   Xueguan, Zhang ^c  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

AFP IgM immune complexes; Alpha fetoprotein; Hepatocellular carcinoma; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER STAGING; CHEMOLUMINESCENCE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIGEN-ANTIBODY COMPLEX; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; ELECTROCHEMICAL TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; LIVER NEOPLASMS; LUMINESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 68049101887     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20321     Document Type: Article

References (32)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. (Pubitemid 29114292)
3. Spencer SS, Lindqvist KJ, Nantulya VM. A study of alpha-fetoprotein in primary liver cancer in Tanzania. East Afr Med J 1991;68:595-600.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 29094960)
5. Zhang S, Li L, Lu F. Mortality of primary liver cancer in China from 1990 through 1992. Zhonghua Zhong Liu Za Zhi 1999;21:245-249.
6. Benvegnu L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74:2442-2448. (Pubitemid 24320846)
7. Merican I. Screening for hepatocellular carcinoma. Med J Malaysia 1996;51:12-17.
8. Mendez-Sanchez N, Aguilar-Ramirez JR, Reyes A, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004;3:30-33.
9. Llovet JM, Beaugrand M. Hepatocellular carcinoma: Present status and future prospects. J Hepatol 2003;38:S136-S149. (Pubitemid 36286568)
10. Alter HJ. HCV natural history: The retrospective and prospective in perspective. J Hepatol 2005;43:550-552.
11. Omata M, Yoshida H. Resolution of liver cirrhosis and prevention of hepatocellular carcinoma by interferon therapy against chronic hepatitis C. Scand J Gastroenterol Suppl 2003;237:47-51. (Pubitemid 36609880)
12. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607-612. (Pubitemid 40395547)
13. Marrero JA, Lok AS. Newer markers for hepatocellular carcinoma. Gastroenterology 2004;127:S113-S119.
14. Sato Y, Nakata K, Kato Y, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993;328:1802-1806. (Pubitemid 23174710)
15. Martel N, Tuyns AJ, Sizaret P. Alpha-fetoprotein levels in normal individuals. Relative stability over time. Digestion 1977;16:128-137.
16. Muller F, Sault C, Lemay C, Roussel-Mizon N, Forestier F, Frendo JL. Second trimester two-step trisomy 18 screening using maternal serum markers. Prenat Diagn 2002;22:605-608. (Pubitemid 34839301)
17. Wu W, Yao DF, Yuan YM, et al. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006;5:538-544. (Pubitemid 44782093)
18. Lopez JB, Balasegaram M, Timor J, Thambyrajah V. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma. Malays J Pathol 1997;19:53-58.
19. Beneduce L, Castaldi F, Marino M, et al. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes. Int J Biol Markers 2004;19:155-159. (Pubitemid 39106942)
20. Giannelli G, Fransvea E, Trerotoli P, et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 2007;383:147-152. (Pubitemid 47016463)
21. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
22. Sobin LH, Wittekind C, editors. 2002. TNM Classification of Malignant Tumours, 6th edition. UICC (International Union Against Cancer). New York: Wiley-Liss. 81.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
24. Sherman M, Klein A. AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. Hepatology 2004;40:1465-1473. (Pubitemid 39657024)
25. Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: Comparison of the conventional enzyme immunoassay and two modified methods. Am J Gastroenterol 1996;91:1380-1383. (Pubitemid 26236374)
26. Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-575. (Pubitemid 32328514)
27. Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991. Br J Obstet Gynaecol 1995;102:370-376.
28. El-Serag HB, Mallat DB, Rabeneck L. Management of the single liver nodule in a cirrhotic patient: A decision analysis model. J Clin Gastroenterol 2005;39:152-159. (Pubitemid 40130030)
29. Chapman CE, Fairweather DS, Keeling AA, Chandler ST, Dykes PW, Bradwell AR. Clinical evaluation of anti-alphafetoprotein radioimmunodetection. Br J Radiol 1986;59:1175-1178.
30. Tsuchida Y, Ikeda H, Suzuki N, et al. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein. J Pediatr Surg 1999;34:1762-1764. (Pubitemid 30002477)
31. Hoshino H, Katada N, Nishimura D, et al. Case report: Fibrolamellar hepatocellular carcinoma in a Japanese woman: A case report and review of Japanese cases. J Gastroenterol Hepatol 1996;11:551-555. (Pubitemid 126734023)
32. Kim KA, Lee WJ, Lim HK, et al. Small hepatocellular carcinoma: Ultrasonographic findings and histopathologic correlation. Clin Imaging 2003;27:340-345. (Pubitemid 37025669)